Committee On WIPO Standards Stumbles Over Development Agenda 20/05/2014 by Catherine Saez, Intellectual Property Watch 3 Comments The World Intellectual Property Organization technical committee working on standards to facilitate work of intellectual property offices and their communication had to adjourn its fourth session last week for lack of agreement on the committee’s relationship to the 2007 Development Agenda of the organisation.
Independent Review Of WIPO Development Up For Debate 20/05/2014 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Intellectual Property Organization Committee on Development and Intellectual Property opened this week with a loaded agenda and some politically-charged issues. One of them is an independent assessment of the mandated mainstreaming of a development dimension into the activities of the UN organisation.
US High Court Opens Door To More (And Older) Copyright Suits 20/05/2014 by Steven Seidenberg for Intellectual Property Watch 1 Comment Music, movie, and television companies suffered a major defeat yesterday, when the United States Supreme Court issued its decision in Petrella v. Metro-Goldwyn-Mayer. The ruling will lead to a flood of new copyright infringement suits against these content companies, according to many experts. And content companies may not be the only losers.
UNDP Report Promotes Competition Law To Boost Access To Medicines 19/05/2014 by Catherine Saez, Intellectual Property Watch 2 Comments The United Nations Development Programme has launched a new publication on the use of competition law to promote access to health technologies. The guidebook describes competition law as an underused tool to be harnessed by developing countries and is designed to help them proficiently using it.
WHO Director Chan Stresses Polio, Inequity, Climate, Junk Food, Supremacy Of Health Over Economic Interests 19/05/2014 by William New, Intellectual Property Watch 3 Comments World Health Organization Director General Margaret Chan opened the annual World Health Assembly today with strong calls to address a wide range of top health concerns across the world. This included a call for the global health community to work to assert the primacy of health concerns over economic interests.
Rise In Non-Communicable Diseases In Africa Needs To Be Addressed, Speakers Say 19/05/2014 by Catherine Saez, Intellectual Property Watch Leave a Comment The International Organisation of la Francophonie in collaboration with French pharmaceutical umbrella organisation “les Entreprises du médicaments,” organised a roundtable on non-communicable diseases on the eve of the annual World Health Assembly. Several health ministers as well as various stakeholders were invited to discuss “the fight against non-communicable diseases: a shared responsibility” on 18 May.
External WIPO Members Group Considers DG Investigation 19/05/2014 by Intellectual Property Watch 3 Comments According to sources, members of the Independent Advisory Oversight Committee, an external member state body at the World Intellectual Property Organization, are meeting this week to discuss a possible investigation into allegations made involving the WIPO director general.
New Initiative To Address Lack Of Paediatric-Specific HIV Treatments 19/05/2014 by Catherine Saez, Intellectual Property Watch Leave a Comment As the World Health Assembly, a new partnership has been launched by three major public health actors in the field of HIV treatment. The initiative is meant to find improved treatments for children suffering from HIV/AIDs. Although all actors agree that significant progress has been made on adult treatments, children-specific medicines are still lacking.
WHO Report Compares Prices, IP Status Of HIV Treatment In Middle-Income Countries 16/05/2014 by Julia Fraser for Intellectual Property Watch Leave a Comment A new report from the World Health Organization concludes that prices of HIV treatments vary greatly between middle-income countries (MICs), often depending on patent landscape, licensing agreements, whether drugs were sourced from originator companies, and regulatory approval. For third-line treatments, the price of drugs remains a challenge for all, with newer products more likely to be patented in key countries of production.
IP, R&D Among Issues In Packed Agenda Of 2014 World Health Assembly 16/05/2014 by William New, Intellectual Property Watch 1 Comment The annual World Health Assembly kicks off next week with a full agenda of new and old public health issues, including several related to intellectual property, pricing, and research and development. Below is a guide to the key issues for Intellectual Property Watch readers.